Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: E.J. Neitz Jr who wrote (7049)	8/28/1998 4:52:00 PM
From: John Patterson	Read Replies (1) \| Respond to of 17367

I disagree Ed, if a buyout happens at these levels the small investor will be reamed, however the XOMA BOD, management and other insiders will probably do very well. Long term I think this type of rip off of small investors will exact it's own karmic toll on the larger pharms. There are damned few small investors willing to invest in bio today, if XOMA gets bought out for peanuts then this will be one more lesson learned. Eventually the big pharms will have to start underwriting their own R&D, and that will cost them billions! When you do your homework and are right on the science and yet still lose money, you would be a fool to invest in this sector. Hope I'm wrong.